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Figure S1. Schematic illustrations of the fabrication process for the implantable photovoltaic 
device. (a) Preparation of a polyimide film (thickness: 12.5 µm). (b) Fourteen microcells are 
transfer-printed on the PI film with aids of an adhesive layer (SU-8, thickness ~2 µm). (c) Via 
holes for top and bottom contacts by patterning SU-8. (d) Interconnection metals (Ti/Au) are 
deposited onto the top and bottom contacts. (e) SU-8 and (f) NOA layers are spun on the top 
layer. Layers of PDMS encapsulate the device on the (g) front and (g) back. 
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Figure S2. (a) The cross-sectional view of the IPV device. The inorganic solar materials (red) 
are located in mechanically neutral plane. (b) Dimensions and calculation of the neutral plane.  
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Figure S3. (a) Dimensions used in finite element method (FEM) analysis. (b) FEM results of 
the IPV devices bent with the radii of 3.5 mm, 2.5 mm, 2.15 mm and 1.75 mm. The strains in 
the solar microcells are minimal < 0.1% and < 0.3% with radii of curvature of ~3.5 mm and 
1.75 mm, respectively. 
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Figure S4. (a) Optical image of the IPV device on a cylinder (radius of curvature : 4 mm). 
(b)-(c) Current-voltage characteristics of the IPV device after bending and unbending on 
cylinders whose radii of curvature of 3.5 mm, 2.5 mm, 2.15 mm and 1.75 mm in (b) the outer 
and (c) inner directions. 
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Figure S5. (a) Optical image of cycling tests on a cylinder with a radius of 2.5 mm. (b) 
Measurement results of the tests. There is not noticeable degradation of the efficiency and 
power density even after 1000 cycles. 
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Figure S6. (a) Optical image of the hairless mouse skin mounted on a lower integrating sphere 
within 10 min after isolating from the mouse. (b) Optical image and (c) schematic illustration 
of the optical measurement system consisting of a light source, a pair of double-integrating 
spheres and detectors. Scattered light reflected on the skin or transmitted through skin is 
collected in the detectors. 
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Figure S7. Calculations of the current densities based on the transmittance of the mouse skin, 
photon flux of the irradiation[62] and external quantum efficiency (EQE) of the solar microcells.   
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Figure S8. Transmittance (mean ± SEM, n = 7) measurements of bare skins (black line) and 
the skins (red line) covered with (a) cheek-and-lip stain, (b) moisturizer. (c) Quantum efficiency 
of the solar microcells. 
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Figure S9. (a) Image of the hairless mouse with the IPV device illuminated at a tilted angle. 
(b) Conversion efficiency and electric power density when the implanted IPV device tilted by 
0°, 30°, 45° and 60° from the perpendicular plane to the incident light. At relatively high angle 
(~60°), the subdermal IPV device still generate 38% of power (0.9 mW/cm2) compared the one 
(2.35 mW/cm2) generated without tilting. 
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Figure S10. (a-c) Histological images of the hairless mouse skin tissues, stained with 
hematoxylin and eosin (H&E), with (a) no implant, (b) encapsulation layer only and (c) the IPV 
device after 4 weeks of implantation. (d-f) Histological images of the hairless mouse skin 
tissues, stained with Accustain trichrome stain (Masson) kit (Sigma), with (d) no implant, (e) 
encapsulation layer only and (f) the IPV device after 4 weeks of implantation. 
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Figure S11. Viability of splenocytes, immune cells obtained from spleen of a hairless mouse, 
when exposed directly to the IPV devices, encapsulation layers only, glass slides, ZDEC-PU 
films for 24 hours. Survivability of the immune cells for the IPV device and encapsulation 
layers only is similar with the control (glass). However, survivability with ZDEC-PU films 
decreases down to ~30%. 
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Figure S12. (a) Electric circuit diagram of the subdermally implantable flexible pacemaker 
(R1 = 4.7 MΩ, R2 = 23.8 kΩ, C1 = 100 nF, C2 = 10 nF). (b) Optical image of the flexible 
pacemaker bent on a cylinder with a radius of 2.3 cm. 
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Figure S13. (a) Characteristics of charging and holding of the rechargeable battery by the IPV 
device under skin (left) and the equivalent circuit diagrams (right) when the illumination is 
repetitively on/off. Voltage drop (∆V = 0.15 V) at illumination off is caused by the internal 
resistance in the battery. In the design, the current flowing back through the IPV device while 
illumination off is small because the shunt resistance (0.7-2 MΩ) of the solar microcell is very 
large and turn-on voltage (~4 V) of two diodes in series is greater than the output voltage (3.3 
V) of the battery. For improved pacemakers, an additional power management system should 
be able to shut off any leakage current. (b-c) Charging/loading characteristics (left) and the 
equivalent circuit diagrams (right) of the rechargeable battery and IPV device integrated with 
(b) a LED or (c) subdermally implantable pacemaker. 
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Figure S14. Self-powered pacemaker regulating the heart rate in different frequencies. (a) The 
subdermally implanted self-powered pacemaker powered by the IPV device and battery 
recharged by the IPV device. Inset: optical image of the self-powered pacemaker integrated 
with the IPV device. (b) ECG signal (~5 Hz) of the hairless mouse within ~5 min after opening 
the thoracic cage. (c) Impulses generated from the self-powered pacemaker and (d) regulated 
heart rate of the mouse in ~1 Hz (~10 min after opening of thoracic cage), (e-f) 3 Hz (~30 min 
after opening of thoracic cage) and (g-h) ~5 Hz (~40 min after opening of thoracic cage).  
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Figure S15. Fully implantable electronics integrated with the IPV devices. (a) An electronic 
device (LED) integrated with the IPV device and its equivalent circuit. (b) Current-voltage 
characteristics of the LED. Open-circuit voltage (~4.5 V) of the IPV device is high enough to 
turn on the LED (Vturn-on = 2.4 V). (c) An image of LED light in a live hairless mouse when the 
IPV device is illuminated under AM1.5G. (d) An optical image of the integrated IPV device 
containing a rechargeable battery and the LED, and its equivalent circuit. The current (IP) 
generated by the IPV device turns on the LED (IL) and recharges the battery (IB). (e) Charging 
time of the battery by the IPV device in a standard testing condition (STC, AM1.5G, black solid 
line) and under the skin of a live mouse (red solid line). (f) The integrated IPV device fully 
implanted under the mouse skin. With illumination on, the IPV device power the LED and 
stores energy to the rechargeable battery. With illumination off, the battery powers the LED 
with the stored energy. 
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Figure S16. Calculation of charging time of a rechargeable battery whose capacity is same as 
a battery used in a pacemaker. The calculation indicates that recharging for 2 hr and 6 min 
provides enough energy to run a pacemaker for a day. 
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Figure S17. Weight measurements of the hairless mice with no implant (red), the IPV device 
(blue) and encapsulation only (green) for 21 weeks after implantation. The hairless mouse with 
the IPV device did not lose weight, similar with mice with no implant and encapsulation only. 
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Table S1. Efficiencies of the IPV implanted under skin covered with additional layers such as 
sunscreen, moisturizer, cheek-and-lip stain, hydrocolloid bandage. Conversion efficiency of the 
IPV devices under the skin covered by sunscreen (η = 7.5%, IOPE UV shield sun protector SPF 
50+/PA+++TM, Amorepacific) or moisturizer (η = 7.8%, Shea butter steam cream moistTM, 
Nature republic) is comparable to that (η = 7.8%) with the bare skin only. Sunscreens usually 
designed to block ultraviolet (UV, wavelength: 280-400 nm)[49] affect minimally to 
transmittance of visible light that the IPV devices mostly absorb. Cheek-and-lip stain (Benefit 
cosmetics) or hydrocolloid bandage (thickness ~ 0.53 mm, Boryung) reduce conversion 
efficiency down to 6.1%. 
 
 
Video S1. Regulated heart beat of a hairless mouse (SKH1 HrHr) by the subdemally implanted 
self-powered flexible pacemakers. 
Video S2. A hairless mouse (SKH1 HrHr) with a subdermal IPV device. 
Video S3. A fully implanted LEDs powered by the subdermal IPV device in a hairless mouse 
model (SKH1 HrHr). 
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Video S1 
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Video S2 
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Video S3 
 
